
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Levothyroxine Sodium
Therapeutic Area : Endocrinology
Study Phase : Approved FDF
Recipient : Mannkind
Deal Size : Undisclosed
Deal Type : Agreement
MannKind and Vertice to Co-Promote Thyquidity™ (levothyroxine sodium) Oral Solution
Details : Vertice will make a specified quarterly payment to MannKind to defray the costs of the additional promotional activity and will pay MannKind royalties on gross profit resulting from all sales of Thyquidity.
Product Name : Thyquidity
Product Type : Hormone
Upfront Cash : Undisclosed
December 17, 2020
Lead Product(s) : Levothyroxine Sodium
Therapeutic Area : Endocrinology
Highest Development Status : Approved FDF
Recipient : Mannkind
Deal Size : Undisclosed
Deal Type : Agreement
